CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for WDB coco Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

WDB coco Co Ltd
27F, Triton Square Y, 1-8-11, Harumi
Phone: +81 351442250p:+81 351442250 CHUO-KU, TKY  104-6127  Japan Ticker: 70797079

Business Summary
WDB coco CO., LTD. is a Japan-based company engaged in the contract development of pharmaceutical companies. The Company is engaged in the provision of safety information management service as an agent and support for drug development, document support service, development support service and clinical development support service. The safety information management service provides support services such as input, evaluation drafting and report drafting. The document support service provides support services from QC (quality assurance) and translation of documents and materials necessary for marketing approval to PMDA (Pharmaceuticals and Medical Devices Agency) to the creation of approval application called CTD (Common Technical Document). The development support service provides services such as survey form management, filing of survey-related documents and call center operations. The clinical development support service provides support services for clinical trial related work.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20203/31/2020Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Representative Director HaruhikoTaniguchi 44 11/1/2014
Chief Director of Administration, Director of Business Administration, Director SokoFujiwara 43 2/1/2019
Chief Director of Contract Business, Director of Commissioned Human Resources Development, Director HatsuneNishimori 37 1/1/2019
Director ToshimitsuNakano 63
Independent Director KentaYokogawa 41 6/1/2019 6/1/2019

General Information
Number of Employees: 277 (As of 3/31/2020)
Outstanding Shares: 2,285,000 (As of 3/31/2020)
Shareholders: 1,281
Stock Exchange: TYO
Fax Number: +81 335343911


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 3, 2020